Source link : https://www.newshealth.biz/health-news/should-all-diabetic-ketoacidosis-be-treated-the-same/
TOPLINE: Sodium-glucose cotransporter 2 inhibitor (SGLT2i)-associated diabetes ketoacidosis (DKA) in people with type 2 diabetes (T2D) is associated with lower degrees of hyperglycemia over the first 24 hours of treatment than seen in type 1 diabetes (T1D)-associated DKA, potentially leading to hypo- or hyperglycemia if the same insulin infusion protocols are used. METHODOLOGY: Retrospective cohort […]
Author : News Health
Publish date : 2024-03-20 11:31:19
Copyright for syndicated content belongs to the linked Source.